Avidity Biosciences
RNAM
#1794
Rank
NZ$19.69 B
Marketcap
NZ$127.50
Share price
0.00%
Change (1 day)
147.83%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: NZ$19.69 Billion

As of April 2026 Avidity Biosciences has a market cap of NZ$19.69 Billion. This makes Avidity Biosciences the world's 1794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.69 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$282.05 B 1,332.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$198.36 B 907.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$4.27 B-78.32%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.82 B-50.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.24 B-98.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.43 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.14 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$5.31 B-73.02%๐Ÿ‡บ๐Ÿ‡ธ USA